 |
PDBsum entry 1d9n
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Gene regulation
|
PDB id
|
|
|
|
1d9n
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
EMBO J
18:6653-6661
(1999)
|
|
PubMed id:
|
|
|
|
|
| |
|
Solution structure of the methyl-CpG-binding domain of the methylation-dependent transcriptional repressor MBD1.
|
|
I.Ohki,
N.Shimotake,
N.Fujita,
M.Nakao,
M.Shirakawa.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
CpG methylation in vertebrates is important for gene silencing, alterations in
chromatin structure and genomic stability, and differences in the
DNA-methylation status are correlated with imprinting phenomena, carcinogenesis
and embryonic development. Methylation signals are interpreted by protein
factors that contain shared methyl-CpG-binding domains (MBDs). We have
determined the solution structure of the MBD of the human methylation-dependent
transcriptional repressor MBD1 by multi-dimensional heteronuclear NMR
spectroscopy. It folds into an alpha/beta-sandwich structure with characteristic
loops. Basic residues conserved in the MBD family are largely confined to one
face of this fold and a flexible loop, which together form a large positively
charged surface. Site-directed mutagenesis and chemical shift changes upon
complexing with a methylated DNA facilitated identification of this surface as
the DNA interaction site. In addition to three basic residues, conserved Tyr34
and Asp32 were shown to be important for the DNA binding.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
Figure 3 Surface diagrams of MBD1 MBD. (A) The protein surface
(Nicholls et al., 1991) viewed in the same orientation as in
Figure 2. The conserved basic and acidic residues are colored in
blue and green, respectively. The hydrophobic superficial
patches made up of the conserved residues are colored in yellow.
The location of Ser45 is also indicated. (B) Distribution of the
electrostatic potential on the solvent-accessible surface
(Nicholls et al., 1991). Blue corresponds to positive potential
and red to negative potential.
|
 |
Figure 6.
Figure 6 Putative DNA binding site of MBD. Stick representation
(Koradi et al., 1996) of the MBD with selected conserved
residues in the proposed DNA binding site. Basic residues are
colored in blue; aromatic residues, yellow; an acidic residue,
green. Main chains of residues strongly affected by addition of
methyl-CpG DNA are colored in red ( [av]/
[max]
>0.1). The molecule is rotated approximately -90° about the
vertical axis relative to that shown in Figures 2. B-form DNA is
also shown in the left-hand figure, with methyl groups in the
symmetric methyl-CpG highlighted in yellow. With the DNA binding
site placed in the major groove of the B-form DNA, loop L1 and
the linker between strand 4
and helix 1
are located close to the phosphate backbone. The side chains of
Tyr34 and Asp32 can come into contact with the methyl-CpG.
|
 |
|
|
|
| |
The above figures are
reprinted
from an Open Access publication published by Macmillan Publishers Ltd:
EMBO J
(1999,
18,
6653-6661)
copyright 1999.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
K.Yamagata,
and
Y.Okada
(2011).
Understanding paternal genome demethylation through live-cell imaging and siRNA.
|
| |
Cell Mol Life Sci,
68,
1669-1679.
|
 |
|
|
|
|
 |
O.Bogdanović,
and
G.J.Veenstra
(2009).
DNA methylation and methyl-CpG binding proteins: developmental requirements and function.
|
| |
Chromosoma,
118,
549-565.
|
 |
|
|
|
|
 |
S.Nakamura,
K.Kuroki,
I.Ohki,
K.Sasaki,
M.Kajikawa,
T.Maruyama,
M.Ito,
Y.Kameda,
M.Ikura,
K.Yamamoto,
N.Matsumoto,
and
K.Maenaka
(2009).
Molecular basis for E-cadherin recognition by killer cell lectin-like receptor G1 (KLRG1).
|
| |
J Biol Chem,
284,
27327-27335.
|
 |
|
|
|
|
 |
A.Dhasarathy,
and
P.A.Wade
(2008).
The MBD protein family-reading an epigenetic mark?
|
| |
Mutat Res,
647,
39-43.
|
 |
|
|
|
|
 |
A.Kumar,
S.Kamboj,
B.M.Malone,
S.Kudo,
J.L.Twiss,
K.J.Czymmek,
J.M.LaSalle,
and
N.C.Schanen
(2008).
Analysis of protein domains and Rett syndrome mutations indicate that multiple regions influence chromatin-binding dynamics of the chromatin-associated protein MECP2 in vivo.
|
| |
J Cell Sci,
121,
1128-1137.
|
 |
|
|
|
|
 |
K.L.Ho,
I.W.McNae,
L.Schmiedeberg,
R.J.Klose,
A.P.Bird,
and
M.D.Walkinshaw
(2008).
MeCP2 binding to DNA depends upon hydration at methyl-CpG.
|
| |
Mol Cell,
29,
525-531.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
T.Clouaire,
and
I.Stancheva
(2008).
Methyl-CpG binding proteins: specialized transcriptional repressors or structural components of chromatin?
|
| |
Cell Mol Life Sci,
65,
1509-1522.
|
 |
|
|
|
|
 |
S.E.Brown,
and
M.Szyf
(2007).
Epigenetic programming of the rRNA promoter by MBD3.
|
| |
Mol Cell Biol,
27,
4938-4952.
|
 |
|
|
|
|
 |
S.Kobayakawa,
K.Miike,
M.Nakao,
and
K.Abe
(2007).
Dynamic changes in the epigenomic state and nuclear organization of differentiating mouse embryonic stem cells.
|
| |
Genes Cells,
12,
447-460.
|
 |
|
|
|
|
 |
J.Zlatanova
(2005).
MeCP2: the chromatin connection and beyond.
|
| |
Biochem Cell Biol,
83,
251-262.
|
 |
|
|
|
|
 |
R.J.Klose,
S.A.Sarraf,
L.Schmiedeberg,
S.M.McDermott,
I.Stancheva,
and
A.P.Bird
(2005).
DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG.
|
| |
Mol Cell,
19,
667-678.
|
 |
|
|
|
|
 |
T.C.Galvão,
and
J.O.Thomas
(2005).
Structure-specific binding of MeCP2 to four-way junction DNA through its methyl CpG-binding domain.
|
| |
Nucleic Acids Res,
33,
6603-6609.
|
 |
|
|
|
|
 |
A.Bird,
and
D.Macleod
(2004).
Reading the DNA methylation signal.
|
| |
Cold Spring Harb Symp Quant Biol,
69,
113-118.
|
 |
|
|
|
|
 |
H.F.Jørgensen,
I.Ben-Porath,
and
A.P.Bird
(2004).
Mbd1 is recruited to both methylated and nonmethylated CpGs via distinct DNA binding domains.
|
| |
Mol Cell Biol,
24,
3387-3395.
|
 |
|
|
|
|
 |
A.Zemach,
and
G.Grafi
(2003).
Characterization of Arabidopsis thaliana methyl-CpG-binding domain (MBD) proteins.
|
| |
Plant J,
34,
565-572.
|
 |
|
|
|
|
 |
B.Heitmann,
T.Maurer,
J.M.Weitzel,
W.H.Strätling,
H.R.Kalbitzer,
and
E.Brunner
(2003).
Solution structure of the matrix attachment region-binding domain of chicken MeCP2.
|
| |
Eur J Biochem,
270,
3263-3270.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
B.Hendrich,
and
S.Tweedie
(2003).
The methyl-CpG binding domain and the evolving role of DNA methylation in animals.
|
| |
Trends Genet,
19,
269-277.
|
 |
|
|
|
|
 |
H.Fujita,
R.Fujii,
S.Aratani,
T.Amano,
A.Fukamizu,
and
T.Nakajima
(2003).
Antithetic effects of MBD2a on gene regulation.
|
| |
Mol Cell Biol,
23,
2645-2657.
|
 |
|
|
|
|
 |
M.F.Fraga,
E.Ballestar,
G.Montoya,
P.Taysavang,
P.A.Wade,
and
M.Esteller
(2003).
The affinity of different MBD proteins for a specific methylated locus depends on their intrinsic binding properties.
|
| |
Nucleic Acids Res,
31,
1765-1774.
|
 |
|
|
|
|
 |
M.S.Hung,
and
C.K.Shen
(2003).
Eukaryotic methyl-CpG-binding domain proteins and chromatin modification.
|
| |
Eukaryot Cell,
2,
841-846.
|
 |
|
|
|
|
 |
N.Fujita,
S.Watanabe,
T.Ichimura,
Y.Ohkuma,
T.Chiba,
H.Saya,
and
M.Nakao
(2003).
MCAF mediates MBD1-dependent transcriptional repression.
|
| |
Mol Cell Biol,
23,
2834-2843.
|
 |
|
|
|
|
 |
P.Wu,
C.Qiu,
A.Sohail,
X.Zhang,
A.S.Bhagwat,
and
X.Cheng
(2003).
Mismatch repair in methylated DNA. Structure and activity of the mismatch-specific thymine glycosylase domain of methyl-CpG-binding protein MBD4.
|
| |
J Biol Chem,
278,
5285-5291.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.Kudo,
Y.Nomura,
M.Segawa,
N.Fujita,
M.Nakao,
C.Schanen,
and
M.Tamura
(2003).
Heterogeneity in residual function of MeCP2 carrying missense mutations in the methyl CpG binding domain.
|
| |
J Med Genet,
40,
487-493.
|
 |
|
|
|
|
 |
T.C.Roloff,
H.H.Ropers,
and
U.A.Nuber
(2003).
Comparative study of methyl-CpG-binding domain proteins.
|
| |
BMC Genomics,
4,
1.
|
 |
|
|
|
|
 |
A.J.Warren
(2002).
Eukaryotic transcription factors.
|
| |
Curr Opin Struct Biol,
12,
107-114.
|
 |
|
|
|
|
 |
H.F.Jørgensen,
and
A.Bird
(2002).
MeCP2 and other methyl-CpG binding proteins.
|
| |
Ment Retard Dev Disabil Res Rev,
8,
87-93.
|
 |
|
|
|
|
 |
H.Sakai,
T.Urano,
K.Ookata,
M.H.Kim,
Y.Hirai,
M.Saito,
Y.Nojima,
and
F.Ishikawa
(2002).
MBD3 and HDAC1, two components of the NuRD complex, are localized at Aurora-A-positive centrosomes in M phase.
|
| |
J Biol Chem,
277,
48714-48723.
|
 |
|
|
|
|
 |
M.Saito,
and
F.Ishikawa
(2002).
The mCpG-binding domain of human MBD3 does not bind to mCpG but interacts with NuRD/Mi2 components HDAC1 and MTA2.
|
| |
J Biol Chem,
277,
35434-35439.
|
 |
|
|
|
|
 |
M.Shiraishi,
A.J.Oates,
and
T.Sekiya
(2002).
An overview of the analysis of DNA methylation in mammalian genomes.
|
| |
Biol Chem,
383,
893-906.
|
 |
|
|
|
|
 |
S.Hammer,
N.Dorrani,
J.Dragich,
S.Kudo,
and
C.Schanen
(2002).
The phenotypic consequences of MECP2 mutations extend beyond Rett syndrome.
|
| |
Ment Retard Dev Disabil Res Rev,
8,
94-98.
|
 |
|
|
|
|
 |
A.Bellacosa
(2001).
Role of MED1 (MBD4) Gene in DNA repair and human cancer.
|
| |
J Cell Physiol,
187,
137-144.
|
 |
|
|
|
|
 |
E.Ballestar,
and
A.P.Wolffe
(2001).
Methyl-CpG-binding proteins. Targeting specific gene repression.
|
| |
Eur J Biochem,
268,
1-6.
|
 |
|
|
|
|
 |
E.Ballestar,
L.A.Pile,
D.A.Wassarman,
A.P.Wolffe,
and
P.A.Wade
(2001).
A Drosophila MBD family member is a transcriptional corepressor associated with specific genes.
|
| |
Eur J Biochem,
268,
5397-5406.
|
 |
|
|
|
|
 |
I.Ohki,
N.Shimotake,
N.Fujita,
J.Jee,
T.Ikegami,
M.Nakao,
and
M.Shirakawa
(2001).
Solution structure of the methyl-CpG binding domain of human MBD1 in complex with methylated DNA.
|
| |
Cell,
105,
487-497.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
E.Ballestar,
T.M.Yusufzai,
and
A.P.Wolffe
(2000).
Effects of Rett syndrome mutations of the methyl-CpG binding domain of the transcriptional repressor MeCP2 on selectivity for association with methylated DNA.
|
| |
Biochemistry,
39,
7100-7106.
|
 |
|
|
|
|
 |
N.Fujita,
N.Shimotake,
I.Ohki,
T.Chiba,
H.Saya,
M.Shirakawa,
and
M.Nakao
(2000).
Mechanism of transcriptional regulation by methyl-CpG binding protein MBD1.
|
| |
Mol Cell Biol,
20,
5107-5118.
|
 |
|
|
|
|
 |
N.K.Kaludov,
and
A.P.Wolffe
(2000).
MeCP2 driven transcriptional repression in vitro: selectivity for methylated DNA, action at a distance and contacts with the basal transcription machinery.
|
| |
Nucleic Acids Res,
28,
1921-1928.
|
 |
|
|
|
|
 |
T.M.Yusufzai,
and
A.P.Wolffe
(2000).
Functional consequences of Rett syndrome mutations on human MeCP2.
|
| |
Nucleic Acids Res,
28,
4172-4179.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |